Literature DB >> 27581534

Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.

Ai Ibaraki1,2, Wataru Goto3, Rie Iura3, Mitsuhiro Tominaga2, Takuya Tsuchihashi1,2.   

Abstract

The guidelines for the management of hypertension recommend the inclusion of diuretics, especially when three or more antihypertensive drugs are used. The present study investigated the current prescription status of antihypertensive drugs with a particular focus on the use of diuretics in a local district in Japan. Prescriptions, including antihypertensive drugs, were collected from a dispensing pharmacy of the Yahata Pharmacist Association, located in Kitakyushu City, in October 2014. Of the 10 585 prescriptions, calcium channel blockers (CCBs) were prescribed in 73.5%, followed by angiotensin II receptor blockers (ARB, 62.7%), diuretics (16.5%) and β-blockers (13.6%). The average number of drugs used was 1.80. The rates of prescription of diuretics for patients with one, two, three and four drugs were 0.6%, 13.1%, 55.2% and 82.6%, respectively. Diuretics were more frequently prescribed in elderly patients, and the prescription rate of doctors in hospitals was significantly higher than that of general practitioners (19.1% vs. 15.7%, P<0.01). In addition, 40% of patients with thiazide diuretics were prescribed combination tablets of hydrochlorothiazide with ARB, whereas trichlormethiazide (34.9%) and indapamide (19.8%) were used in other patients. Based on these findings, the use of diuretics remains limited, even among patients taking multiple antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27581534     DOI: 10.1038/hr.2016.120

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  14 in total

1.  Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yusuke Ishikawa; Yoshihiro Mori; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  Hypertension       Date:  2014-08-25       Impact factor: 10.190

2.  Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.

Authors:  Hiromi Rakugi; Takuya Tsuchihashi; Kazuyuki Shimada; Hirotaka Numaguchi; Chisato Nishida; Hiroya Yamaguchi; Masayoshi Shirakawa; Kyoichi Azuma; Kenji P Fujita
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

3.  Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance.

Authors:  Hajime Hasegawa; Koichi Kanozawa; Juko Asakura; Kaori Takayanagi; Osamu Komuro; Hiroyuki Fukada; Hidetsugu Tokushima; Hisaya Kogure; Masatoshi Matsuzawa; Tetsuya Mitarai
Journal:  Hypertens Res       Date:  2013-04-25       Impact factor: 3.872

4.  Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials.

Authors:  Hiromi Rakugi; Takuya Tsuchihashi; Kazuyuki Shimada; Hirotaka Numaguchi; Chisato Nishida; Hiroya Yamaguchi; Go Fujimoto; Kyoichi Azuma; Masayoshi Shirakawa; Mary E Hanson; Kenji P Fujita
Journal:  Hypertens Res       Date:  2014-07-03       Impact factor: 3.872

5.  Characteristics of the hypertensive patients with good and poor compliance to long-term salt restriction.

Authors:  Minako Sakaki; Takuya Tsuchihashi; Kimika Arakawa
Journal:  Clin Exp Hypertens       Date:  2014       Impact factor: 1.749

6.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Authors:  Kazuaki Shimamoto; Katsuyuki Ando; Toshiro Fujita; Naoyuki Hasebe; Jitsuo Higaki; Masatsugu Horiuchi; Yutaka Imai; Tsutomu Imaizumi; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Hiroshi Itoh; Hiroshi Iwao; Hisashi Kai; Kazuomi Kario; Naoki Kashihara; Yuhei Kawano; Shokei Kim-Mitsuyama; Genjiro Kimura; Katsuhiko Kohara; Issei Komuro; Hiroo Kumagai; Hideo Matsuura; Katsuyuki Miura; Ryuichi Morishita; Mitsuhide Naruse; Koichi Node; Yusuke Ohya; Hiromi Rakugi; Ikuo Saito; Shigeyuki Saitoh; Kazuyuki Shimada; Tatsuo Shimosawa; Hiromichi Suzuki; Kouichi Tamura; Norio Tanahashi; Takuya Tsuchihashi; Makoto Uchiyama; Shinichiro Ueda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2014-04       Impact factor: 3.872

Review 7.  Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis.

Authors:  Rik H G Olde Engberink; Wijnanda J Frenkel; Bas van den Bogaard; Lizzy M Brewster; Liffert Vogt; Bert-Jan H van den Born
Journal:  Hypertension       Date:  2015-03-02       Impact factor: 10.190

Review 8.  Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.

Authors:  George C Roush; Michael E Ernst; John B Kostis; Suraj Tandon; Domenic A Sica
Journal:  Hypertension       Date:  2015-03-02       Impact factor: 10.190

9.  Long-term compliance with salt restriction in Japanese hypertensive patients.

Authors:  Yuko Ohta; Takuya Tsuchihashi; Uran Onaka; Kimika Eto; Mitsuhiro Tominaga; Michio Ueno
Journal:  Hypertens Res       Date:  2005-12       Impact factor: 3.872

Review 10.  Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.

Authors:  George C Roush; Theodore R Holford; Achuta K Guddati
Journal:  Hypertension       Date:  2012-04-23       Impact factor: 10.190

View more
  3 in total

1.  Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.

Authors:  Shin Kawasoe; Yukiko Maruguchi; Shoko Kajiya; Hitoshi Uenomachi; Masaaki Miyata; Mariko Kawasoe; Takuro Kubozono; Mitsuru Ohishi
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-10       Impact factor: 2.483

2.  Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.

Authors:  Takayuki Ishida; Akinori Oh; Nobuhiro Nishigaki; Takuya Tsuchihashi
Journal:  Geriatr Gerontol Int       Date:  2019-08-21       Impact factor: 2.730

3.  Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect.

Authors:  Shuichi Ichikawa; Junko Tsutsumi; Kotaro Sugimoto; Satoru Yamakawa
Journal:  Adv Ther       Date:  2022-08-17       Impact factor: 4.070

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.